HAL (France)
open access
Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia#888560
- The Bruton Tyrosine Kinase Inhibitor PCI-32765 Blocks B-cell Activation And Is Efficacious In Models Of Autoimmune Disease And B-cell Malignancy#1148409
- Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients#1150559
- Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome#860139
- A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies#911963
Record · ID 350582
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive